Apontis Pharma’s €101 Million Initial Public Offering

McDermott Will & Emery acted as Transaction Counsel for the issuer, its main shareholder Paragon Partners as well as the Joint Bookrunners Hauck & Aufhäuser and…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now